Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 170 | 1,000 | 0 | 0 | 0 |
| Gross Profit | 170 | 1,000 | N/A | N/A | N/A |
| Operating Expenses | 18,379 | 23,409 | 25,708 | 57,601 | 29,050 |
| Operating Income | -18,209 | -22,409 | -25,708 | -57,601 | -29,050 |
| Other Income | 661 | 1,626 | 2,538 | 897 | 76 |
| Pre-tax Income | -17,548 | -20,783 | -23,170 | -56,704 | -28,974 |
| Income Tax | -962 | -798 | -2,330 | -2,479 | -1,508 |
| Net Income Continuous | -16,586 | -19,985 | -20,840 | -54,225 | -27,466 |
| Net Income | $-16,586 | $-19,985 | $-20,840 | $-54,225 | $-27,466 |
| EPS Basic Total Ops | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| EPS Basic Continuous Ops | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| EPS Diluted Total Ops | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| EPS Diluted Continuous Ops | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| EPS Diluted Before Non-Recurring Items | -1.91 | -2.40 | -2.58 | -4.07 | -7.50 |
| EBITDA(a) | $-18,138 | $-22,690 | $-26,479 | $-56,744 | $-26,481 |